Background illustration for clinical trials search

Paid Clinical Trials Shreveport

Discover 137 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

for
Sleep Apnea, Obstructive, Obesity, Overweight
Location: Shreveport LA, Aurora CO
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07369011

Phase 3, Recruiting
FeaturedActive & Responsive

Obstructive Sleep Apnea Studies for Adults With a BMI of 27+ Who Could Not Tolerate CPAP

for
Sleep Apnea, Obstructive
Location: Shreveport LA, Dallas TX, Tomball TX, Anderson SC,

Sex: All

Age: 18+

Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Shreveport LA, Dallas TX, Houston TX, Katy TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Bossier City LA, Shreveport LA, West Monroe LA,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Phase 4, Recruiting
Active & Responsive

EASi-PROTKTā„¢ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Bossier City LA, Shreveport LA, West Monroe LA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Location: Bossier City LA, Shreveport LA, Little Rock AR,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06911632

Recruiting
Active & Responsive

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Shreveport LA, Monroe LA, Little Rock AR, Fort Smith AR,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07018869

Phase 3, Recruiting
Active & Responsive

Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: Shreveport LA, Little Rock AR, Frisco TX,
Sponsor: CGBio Inc.

Sex: All

Age: 21 - 70+

Code: NCT07017634

Phase 3, Recruiting
Active & Responsive

STRIVE Post-Market Registry Study

for
Emphysema
Location: Shreveport LA, Dallas TX, Houston TX, Gulfport MS,
Sponsor: Olympus Corporation of the Americas

Sex: All

Age: 18+

Code: NCT04302272

Recruiting
Active & Responsive

Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems

for
Fetal Hypoxia, Fetal Acidemia
Location: Shreveport LA
Sponsor: Raydiant Oximetry, Inc.

Sex: Female

Age: 18+

Code: NCT07296419

Recruiting
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
Location: Shreveport LA, Dallas TX, Baton Rouge LA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Shreveport LA, West Monroe LA, Bastrop LA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Shreveport LA, West Monroe LA, Bastrop LA, Forney TX,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Shreveport LA, Longview TX, Sherwood AR, Jackson MS,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase 2, Phase 3, Recruiting
Active & Responsive

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Shreveport LA, McKinney TX, Tomball TX, Cypress TX,
Sponsor: Expedition Therapeutics, Inc

Sex: All

Age: 40 - 70+

Code: NCT07684820

Phase 2, Recruiting
Active & Responsive

ACP-204 in Adults With Alzheimer's Disease Psychosis

for
Alzheimer's Disease Psychosis
Location: Shreveport LA, Cypress TX, Pasadena TX, Houston TX,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 55 - 70+

Code: NCT06159673

Phase 2, Phase 3, Recruiting
Active & Responsive

Caris Biorepository Research Protocol

for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Shreveport LA, Texarkana TX, Alexandria LA,
Sponsor: Caris Science, Inc.

Sex: All

Age: 18+

Code: NCT01499394

Recruiting
Active & Responsive

Motiva ImplantsĀ® Post-Approval Study

for
Breast Implant
Location: Shreveport LA, Dallas TX, Southlake TX, Houston TX,
Sponsor: Motiva USA LLC

Sex: Female

Age: 22+

Code: NCT06938399

Recruiting
Active & Responsive

Prospective US Radiofrequency SUI Trial

for
Urinary Incontinence, Stress
Location: Shreveport LA, Irving TX, Houston TX, League City TX,
Sponsor: Viveve Inc.

Sex: Female

Age: 18+

Code: NCT04720352

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Shreveport LA, Monroe LA, Little Rock AR, Fort Smith AR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting